Journal profile · Immunology
Immunology and Cell Biology
ISSN 0818-9641 · eISSN 1440-1711 · John Wiley & Sons Inc. · AUSTRALIA · Bimonthly
Immunology and Cell Biology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.28; hybrid open access; APC about USD 3,750; median 126 days to acceptance (51 articles, last 24 months); community-reported acceptance: moderate; 106 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Immunology and Cell Biology is published by John Wiley & Sons Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Immune Cell Function and Interaction, T-cell and B-cell Immunology and Immunotherapy and Immune Responses, together about 46.2% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
Immunology & Cell Biology focuses on the general functioning of the immune system in its broadest sense, with a particular emphasis on its cell biology. Areas that are covered include but are not limited to: Immunological studies in humans and animals, including model organisms Cellular immunology Innate and adaptive immunity Immune responses to pathogens Tumour immunology Immunopathology Immunotherapy Immunogenetics Evolution of the immune system Neuroimmunology Computational Immunology Methods papers (with a clear benefit to the immunology community) Immunology Education (for articles including a research component) This leading journal has an established international reputation, built on 100 years of innovative publishing. Abstracting and Indexing Information Abstracts on Hygiene & Communicable Diseases (CABI) Academic Search Alumni Edition (EBSCO Publishing) Academic Search Complete (EBSCO Publishing) Academic Search Elite (EBSCO Publishing) Academic Search Premier (EBSCO Publishing) Academic Search Ultimate (EBSCO Publishing) Advanced Placement Source (EBSCO Publishing) AgBiotechNet (CABI) Agricultural Economics Database (CABI) Animal Breeding Abstracts (CABI) Animal Production Database (CABI) Animal Science Database (CABI) Biological & Agricultural Index Plus (EBSCO Publishing) Biological Abstracts (Clarivate Analytics) Biomedical Reference Collection (EBSCO Publishing) BIOSIS Previews (Clarivate Analytics) Biotechnology Source (EBSCO Publishing) CAB Abstracts® (CABI) CAS: Chemical Abstracts Service (ACS) Consumer Health Complete (EBSCO Publishing) Current Contents: Life Sciences (Clarivate Analytics) Dairy Science Abstracts (CABI) Embase (Elsevier) Forest Science Database (CABI) GeoRef (AGI) Global Health (CABI) Health & Medical Collection (ProQuest) Health Research Premium Collection (ProQuest) Health Source Nursing/Academic (EBSCO Publishing) Helminthological Abstracts (CABI) Horticultural Science Abstracts (CABI) Hospital Premium Collection (ProQuest) Leisure Tourism Database (CABI) MEDLINE/PubMed (NLM) Nutrition & Food Sciences Database (CABI) Nutrition Abstracts & Reviews Series A: Human & Experimental (CABI) OmniFile Full Text Mega Edition (HW Wilson) OmniFile Full Text Select (HW Wilson) Parasitology Database (CABI) Pig News & Information (CABI) Plant Protection Database (CABI) Poultry Abstracts (CABI) ProQuest Central (ProQuest) Protozoological Abstracts (CABI) Review of Medical & Veterinary Entomology (CABI) Review of Medical & Veterinary
From the journal's Aims & Scope
Research area (LetPub): Immunology
Editorial board by country: 1 in mainland China (about 20%); most named Australia 3, Mainland China 1, New Zealand 1 (5 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Immune Cell Function and InteractionImmunology and Microbiology17.7%
- T-cell and B-cell ImmunologyImmunology and Microbiology16.9%
- Immunotherapy and Immune ResponsesImmunology and Microbiology11.7%
- Immune Response and InflammationImmunology and Microbiology8.8%
- Monoclonal and Polyclonal Antibodies ResearchMedicine4.8%
- Genomics and Phylogenetic StudiesBiochemistry, Genetics and Molecular Biology3.1%
- CAR-T cell therapy researchMedicine2.9%
- Viral Infections and VectorsMedicine2.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cell Biology | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cell Biology | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cell Biology | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbaseCASCAB AbstractsGeoRefCurrent ContentsPublisher website
Other: EBSCO, ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.28LetPub ·
- Impact factor (publisher)
- 3.3Publisher website ·
- Impact factor (publisher) 2025
- 3.3Publisher website ·
- CiteScore 2026-06
- 4.7LetPub ·
- CiteScore (publisher)
- 4.7Publisher website ·
- CiteScore (publisher) 2025
- 4.7Publisher website ·
- SJR 2026-06
- 1.08LetPub ·
- SNIP 2026-06
- 0.71LetPub ·
- h-index
- 96LetPub ·
- h-index
- 152OpenAlex ·
- i10-index
- 3,801OpenAlex ·
- 2-year mean citedness
- 2.01OpenAlex ·
- Self-citation rate
- 6.1%LetPub ·
- Share of gold OA articles
- 50.76%LetPub ·
Volume
- Articles per year
- 62LetPub ·
- Articles per year (publisher) 2025
- 83Publisher website ·
- Downloads per year (publisher) 2025
- 492,365Publisher website ·
Articles by year OpenAlex count · 8,284 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 96 | 55 | 60 |
| 2025 | 106 | 85 | 160 |
| 2024 | 128 | 98 | 442 |
| 2023 | 118 | 101 | 831 |
| 2022 | 110 | 66 | 889 |
| 2021 | 94 | 56 | 1,142 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
126 daysMedian, submission to acceptance · P25–P75 87 days – 182 days
- Acceptance to online
- median 18 days (51 articles)
- Submission to online
- median 149 days
- Sample
- 51 articles with submission and acceptance dates (207 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
- Acceptance rate (publisher)
- 29%Publisher website ·
- Acceptance rate (publisher) 2025
- 29%Publisher website ·
- Submission to first decision
- 6 daysPublisher website ·
- Submission to first decision 2025
- 6 daysPublisher website ·
- Submission to acceptance 2025
- 89 daysPublisher website ·
- Acceptance to publication 2025
- 20 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,750 / EUR 3,120 / GBP 2,500 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- ≤ 250 words
- Reference style
- Vancouver
- First submission
- Free format: the journal's layout is not required
Article types accepted9
- commentariesCommentaries By invitation only, although the Editors are receptive to suggested topics.Length not stated
- editorialThe acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Except where otherwise stated…Length not stated
- editorialsEditorials Description: Brief comments written by the editor(s) of the journal or by guest editor(s) of Special Features based on the contents of the current is…Length not stated
- original articlesOriginal Articles Description: Please see ‘Preparation of Original Articles’ below for further details Abstract: Unstructured Abstract, max 250 words Word Limit…Length not stated
- outstanding observation articlesOutstanding Observation Articles Description: Describe striking reproducible observations that have extremely important conceptual implications but do not neces…Length not stated
- research highlightsResearch Highlights By invitation only, although the Editors are receptive to suggested topics.Length not stated
- reviewsReviews Description: Provide succinct summaries of, respectively, an area or a specific research advance in immunology.Length not stated
- short communicationsShort Communications Abstract: Unstructured Abstract, max 250 words Word Limit: 2,000 words max excluding Methods, figures and tables.Length not stated
- special feature reviewsSpecial Feature Reviews By invitation only, although the Editors are receptive to suggested topics.Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, Open access, Peer review, Preprints, Self-archiving, Trial registration / reporting guidelines
- Authorship Authorship
Please refer to the journal’s Authorship policy in the Editorial Policies and Ethical Considerations section for details on author listing eligibility.
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest Statement
Authors will be asked to provide a Conflict of Interest statement during the submission process. For details on what to include in this section, see the ‘Conflict of Interest’ section in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all Co-authors to confirm agreement with the final statement.
Source ↗Publisher website ·- Data availability Data Sharing and Data Availability
Data sharing expected Model summary
Immunology & Cell Biology expects data sharing. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.
Source ↗Publisher website ·- Publication ethics Publication Ethics
COPE member Model summary
This journal is a member of the Committee on Publication Ethics (COPE) and its Editorial Policies have been guided by the COPE international standards for editors. Note that this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. ICB discourages the use of “text recycling” (i.e. self-plagiarism), and authors may be asked to …
Source ↗Publisher website ·- Open access New Open Access agreement for authors at Australian and New Zealand institutions
From 1 January 2022, the Open Access agreement between Wiley and the Council of Australian University Librarians (CAUL) comes into effect. Immunology & Cell Biology authors affiliated with participating institutions may now publish open access with no transactional Article Publication Charges (APCs). Check whether your institution is eligible here. Follow this guide to check article eligibility an…
Source ↗Publisher website ·- Peer review
Single-anonymous peer review Model summary
Except where otherwise stated, manuscripts are single-anonymous peer reviewed.
Source ↗Publisher website ·- Preprints
Preprinting encouraged Model summary
Immunology & Cell Biology strongly encourages preprinting of articles prior to submissions.
Source ↗Publisher website ·- Self-archiving
Scoop Protection: editorial decision on novelty and importance at the point of submission Model summary
Under this new policy, ICB will remain committed to the editorial decision on novelty and importance at the point of submission.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the Abstract. If the trial is not registered, or was registered retrospectivel…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- John Wiley & Sons Inc.
- Country or region
- AUSTRALIA
- Language
- English
- Frequency
- Bimonthly
- ISSN
- 0818-9641
- Electronic ISSN
- 1440-1711
- Latest issue on the website
- Volume 104, Issue 8 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Immunology and Cell Biology
What CAS zone is Immunology and Cell Biology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Immunology and Cell Biology is in Zone 4 of Medicine, and in Zone 4 of the minor category Cell Biology / Immunology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Immunology and Cell Biology?
The latest impact factor listed by LetPub is 3.28; CiteScore 4.7, h-index 152.
How long does peer review take at Immunology and Cell Biology?
Based on the dates recorded on 51 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 126 days (interquartile range 87–182 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Moderate”; the journal's website gives an acceptance rate of 29% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Immunology and Cell Biology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Reference style: Vancouver; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Immunology and Cell Biology based?
Of the 5 board members whose country the journal's board page names, 1 (about 20%) are in mainland China; the countries named most often are Australia (3), Mainland China (1) and New Zealand (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Immunology and Cell Biology?
According to LetPub and DOAJ records, Immunology and Cell Biology is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, Embase, CAS, CAB Abstracts, GeoRef and Current Contents; that list has not been checked against each database.
Is Immunology and Cell Biology open access, and what is the APC?
Immunology and Cell Biology is a hybrid journal. For open-access publication: APC about USD 3,750.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .